LM103

· Suzhou BlueHorse Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LM103, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: LM103 in Phase IIa Clinical Trial for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer [Phase 2]